| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 69,78 | 69,84 | 14:19 | |
| 69,78 | 69,84 | 14:19 |
| Zeit | Aktuelle Nachrichten
Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Eurofins Scientific: Director/PDMR Shareholding | 392 | Business Wire | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| EUROFINS SCIENTIFIC Aktie jetzt für 0€ handeln | |||||
| Mi | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | 403 | Business Wire | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
| 10.08. | Eurofins Scientific SE: Weekly Report on Share Repurchases from 03rd August to 07th August 2026 | 337 | Business Wire | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument ... ► Artikel lesen | |
| 10.08. | Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 July 2026 | 284 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation... ► Artikel lesen | |
| 07.08. | Eurofins Scientific: Director/PDMR Shareholding | 465 | Business Wire | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| 04.08. | Eurofins Scientific: Director/PDMR Shareholding | 362 | Business Wire | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| 03.08. | Eurofins: Weekly Report on Share Repurchases From 27th July to 31st July 2026 | 314 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily... ► Artikel lesen | |
| 03.08. | Eurofins Scientific SE: Director/PDMR Shareholding | 349 | Business Wire | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| 31.07. | Eurofins Scientific: Director/PDMR Shareholding | 470 | Business Wire | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| 29.07. | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | 342 | Business Wire | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| 27.07. | Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026 | 358 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily... ► Artikel lesen | |
| 24.07. | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | 448 | Business Wire | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| 23.07. | Eurofins Scientific GAAP EPS of €1.64, revenue of €3.70B | 10 | Seeking Alpha | ||
| 23.07. | Schwaches organisches Wachstum belastet Eurofins Scientific Aktie | 38 | Investing.com Deutsch | ||
| 23.07. | Eurofins übernimmt die Geschäftsbereiche Biopharma und Lebensmittelprüfung von Element in Nordamerika | 38 | Bionity.com | ||
| 23.07. | Eurofins Scientific H1 Earnings Rise, Reaffirms FY26, FY27 Outlook | 637 | AFX News | PARIS (dpa-AFX) - Eurofins Scientific SE (ERF.PA), a provider of testing and laboratory services, Thursday reported higher earnings on higher revenue for the first half of the year compared... ► Artikel lesen | |
| 23.07. | Eurofins Scientific verzeichnet schwaches organisches Wachstum im ersten Halbjahr | 29 | Investing.com Deutsch | ||
| 23.07. | Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth | 858 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Financial highlights in H1 2026
Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational... ► Artikel lesen | |
| 21.07. | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | 465 | Business Wire | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| 20.07. | Eurofins To Acquire Element Materials Technology's North American Life Sciences Testing Business For $400 Million | 7 | pulse2.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,565 | -1,09 % | EQS-News: Fresenius SE & Co. KGaA: Fitch Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
Fitch Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
10.08.2026 / 14:30 CET/CEST
Für den... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,950 | -0,22 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,970 | -0,86 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,740 | -1,67 % | Märkte am Morgen: Boeing, Palo Alto, SAP, Infineon, Aixtron, TAG Immobilien, Südzucker, Carl Zeiss | Der DAX dürfte seinen Rekordkurs trotz verhaltener Wall-Street-Vorgaben verteidigen. Im Fokus stehen der wieder steigende Ölpreis, die niedrigen strategischen US-Reserven und die anhaltende Unsicherheit... ► Artikel lesen | |
| ECKERT & ZIEGLER | 13,685 | +0,70 % | Eckert & Ziegler: Q2 review: underlying business solid, valuation attractive: Despite a slight consensus miss with Q2, ... | Eckert & Ziegler reported H1 results: adj. EBIT grew 10% yoy ex license, with the margin up 1.2pp to 22.3%, while reported adj. EBIT fell 6% yoy to € 33.3m against a base carrying € 5m of license income... ► Artikel lesen | |
| INTUITIVE SURGICAL | 338,70 | -0,63 % | Oppenheimer Just Upgraded Intuitive Surgical Stock. Here's Why. | ||
| UNITEDHEALTH | 345,00 | -0,69 % | UnitedHealth nach Margin-Erholung: Ist das Wachstum schon ausgereizt? | UnitedHealth hat die Margenerholung im Kerngeschäft weitgehend eingepreist, doch das Bewertungsniveau signalisiert, dass die nächste Bewährungsprobe im Wachstum liegt. Angesichts eines Kursanstiegs... ► Artikel lesen | |
| DRAEGERWERK | 109,60 | -0,36 % | dpa-AFX-Überblick: UNTERNEHMEN vom 10.08.2026 - 15.15 Uhr | ROUNDUP: Hypoport bestätigt Jahresziele für 2026 - Aktie legt zu BERLIN - Der Finanzdienstleister Hypoport sieht sich auf Kurs zu seinen Jahreszielen. "Die geopolitischen Spannungen des ersten Halbjahres... ► Artikel lesen | |
| MEDTRONIC | 78,02 | -1,12 % | Medtronic structural heart leader appointed CEO of Versa Vascular | ||
| GERRESHEIMER | 27,280 | +0,44 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| THERMO FISHER | 504,20 | -0,83 % | Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist | The transaction establishes an independent company, with the Microbiology business providing the foundation of a global microbiology diagnostics platform serving the clinical, food safety and... ► Artikel lesen | |
| TELADOC HEALTH | 5,900 | +0,14 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| STRATEC | 22,950 | +4,32 % | EQS-News: STRATEC SE: STRATEC mit Ergebnissen für das erste Halbjahr 2026 | EQS-News: STRATEC SE
/ Schlagwort(e): Halbjahresergebnis
STRATEC MIT ERGEBNISSEN FÜR DAS ERSTE HALBJAHR 2026
14.08.2026 / 06:55 CET/CEST
Für... ► Artikel lesen | |
| HEARTFLOW | 42,110 | 0,00 % | Heartflow, Inc.: Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,310 | 0,00 % | Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen |